Bayer Healthcare to gear up for Primovist, Nexavar comarketing

Published: 2009-09-16 06:56:00

Updated: 2009-09-16 06:56:00

Bayer Healthcare has strengthened its presence in the domestic liver market by copromoting its magnetic resonance imaging (MRI) contrast agent Primovist (gadoxetate disodium) for the detection and characterization of liver lesions and Nexavar, liver cancer drug, with a marketing campaign titled “Innovators in the Diagnosis and Treatment of advanced hepatocellular carcinoma.”

Primovist is the...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.